Medicare Enrolled

Dr. Michelle Dompenciel, M.D.

Neurology · Naples, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
12250 TAMIAMI TRL E, Naples, FL 34113
2396875700
In practice since 2008 (17 years)
NPI: 1093950370 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dompenciel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dompenciel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dompenciel

Dr. Michelle Dompenciel is a neurology in Naples, FL, with 17 years in practice. Based on federal Medicare data, Dr. Dompenciel performed 541 Medicare services across 445 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dompenciel received a total of $12,220 from 52 pharmaceutical and/or device companies across 750 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dompenciel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 47% volume in FL$ $12,220 industry payments

Medicare Practice Summary

Medicare Utilization ↗
541
Medicare services
Top 47% in FL for neurology
445
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)282$89$305
New patient office visit, complex (60-74 min)84$146$573
Office visit, established patient, complex (40-54 min)69$134$404
Office visit, established patient (20-29 min)47$70$201
New patient office visit (45-59 min)32$120$437
Needle measurement of electrical activity in arm or leg muscles, complete study27$80$327
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,220
Total received (2018-2024)
Avg $1,746/year across 7 years
Top 25% in FL for neurology
52
Companies
750
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,968 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$252 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$573
2023
$921
2022
$2,318
2021
$2,721
2020
$1,871
2019
$2,107
2018
$1,710

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,754
Biogen, Inc.
$1,344
GENZYME CORPORATION
$941
AbbVie Inc.
$671
Supernus Pharmaceuticals, Inc.
$581
Amgen Inc.
$559
Adamas Pharmaceuticals, Inc.
$535
Lilly USA, LLC
$480
ABBVIE INC.
$469
ACADIA Pharmaceuticals Inc
$429
Genentech USA, Inc.
$383
Alexion Pharmaceuticals, Inc.
$380
Avanir Pharmaceuticals, Inc.
$259
Acorda Therapeutics, Inc
$252
UCB, Inc.
$251
Amneal Pharmaceuticals LLC
$243
EMD Serono, Inc.
$221
US WorldMeds, LLC
$202
PFIZER INC.
$197
Neurocrine Biosciences, Inc.
$187
Lundbeck LLC
$156
CSL Behring
$150
Allergan, Inc.
$140
Celgene Corporation
$139
Neurelis, Inc.
$133
IMPEL PHARMACEUTICALS INC.
$129
Biohaven Pharmaceutical Holding Company Ltd.
$92
Biohaven Pharmaceuticals, Inc.
$86
Merz Pharmaceuticals, LLC
$76
MDD US Operations, LLC
$74
BANNER LIFE SCIENCES, LLC
$74
ARGENX US, INC.
$72
Impax Laboratories, Inc.
$71
Bausch Health US, LLC
$46
ARBOR PHARMACEUTICALS, INC.
$45
Zyla Life Sciences
$42
Teva Pharmaceuticals USA, Inc.
$39
Microtransponder, Inc.
$37
Janssen Pharmaceuticals, Inc
$37
UPSHER-SMITH LABORATORIES LLC
$33
Sunovion Pharmaceuticals Inc.
$30
Arbor Pharmaceuticals, Inc.
$30
SK Life Science, Inc.
$21
Upsher-Smith Laboratories LLC
$19
Zyla Life Sciences, Inc.
$16
Almatica Pharma LLC
$15
Egalet US Inc
$15
Vertical Pharmaceuticals, LLC
$14
Boston Scientific Corporation
$14
GE HealthCare
$14
Currax Pharmaceuticals LLC
$13
Corium, LLC
$12
Top 3 companies account for 33.1% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · AUBAGIO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BodyGuardian · Briviact · CONTRAVE · DISEASE STATE · DaTscan · EMGALITY · GILENYA · GOCOVRI · GRALISE · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · RYTARY · Rebif · SOLIRIS · SPRIX · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · Vimpat · Xadago · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,259 per 100 Medicare services performed
Looking for a neurology in Naples?
Compare neurologys in the Naples area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
27
Per 100K population
7.0
County median income
$86,173
Nearest hospital
WILLOUGH AT NAPLES, THE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dompenciel is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dompenciel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dompenciel performed 282 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dompenciel receive payments from pharmaceutical companies?
Yes. Dr. Dompenciel received a total of $12,220 from 52 companies across 750 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dompenciel's costs compare to other neurologys in Naples?
Dr. Dompenciel's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dompenciel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →